Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Xiaofen Li, Xia Li, Xuefeng Fang, Ying Yuan
  • OncoTargets and Therapy, July 2018, Dove Medical Press
  • DOI: 10.2147/ott.s154567

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/ott.s154567

The following have contributed to this page: Ying Yuan